ASSET | DATE | % RETURN |
---|---|---|
Palladyne AI (PDYNW) | 10/1/2023 - 10/7/2023 | 542.69% |
NLS Pharmaceutics (NLSPW) | 10/1/2023 - 10/7/2023 | 94.81% |
Pasithea Therapeutics Corp Warrant (KTTAW) | 10/1/2023 - 10/7/2023 | 91.94% |
Maison Solutions (MSS) | 10/1/2023 - 10/7/2023 | 83% |
Oncology Institute (TOIIW) | 10/1/2023 - 10/7/2023 | 81.1% |
Clene (CLNNW) | 10/1/2023 - 10/7/2023 | 79.47% |
Alx Oncology Holdings (ALXO) | 10/1/2023 - 10/7/2023 | 74.32% |
BM Technologies Inc WT (BMTX.WT) | 10/1/2023 - 10/7/2023 | 71.31% |
Mobile Global Esports (MGAM) | 10/1/2023 - 10/7/2023 | 64.71% |
LMF Acquisition Opportunities (ICU) | 10/1/2023 - 10/7/2023 | 63.91% |
ParaZero Technologies Ltd Ordinary Shares (PRZO) | 10/1/2023 - 10/7/2023 | 50.06% |
Swiftmerge Acquisition Corp Warrants (IVCPW) | 10/1/2023 - 10/7/2023 | 50% |
DatChat Inc Series A Warrant (DATSW) | 10/1/2023 - 10/7/2023 | 50% |
Matinas BioPharma (MTNB) | 10/1/2023 - 10/7/2023 | 48.8% |
Ostin Technology (OST) | 10/1/2023 - 10/7/2023 | 48.2% |
Akso Health Group ADR (AHG) | 10/1/2023 - 10/7/2023 | 46.08% |
Vivos Therapeutics (VVOS) | 10/1/2023 - 10/7/2023 | 45.55% |
Gaxosai (GXAI) | 10/1/2023 - 10/7/2023 | 44.41% |
BT Brands Inc Warrant (BTBDW) | 10/1/2023 - 10/7/2023 | 41.69% |
Summit Midstream (SMC) | 10/1/2023 - 10/7/2023 | 40.96% |
Nuvalent (NUVL) | 10/1/2023 - 10/7/2023 | 40.38% |
CervoMed (CRVO) | 10/1/2023 - 10/7/2023 | 39.05% |
Elite Education Group International (EEIQ) | 10/1/2023 - 10/7/2023 | 38.27% |
Satellogic Inc Warrant (SATLW) | 10/1/2023 - 10/7/2023 | 35.77% |
Xos Equity Warrants (XOSWW) | 10/1/2023 - 10/7/2023 | 35.14% |